Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Anzueto (San Antonio, United States of America). Recommendations for pharmacological treatment of exacerbations of COPD. International Congress 2017 – Treatment and prevention of COPD exacerbation

Member's Comments

No comment yet.

Related content which might interest you: Pharmacologic treatment of exacerbations of COPD Source: International Congress 2016 – Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline Year: 2016 Therapeutic options for COPD exacerbations Source: International Congress 2014 – PG04 Update on COPD exacerbations Year: 2014 Recommendations on long-term antibiotics and mucolytics for prevention of exacerbations of COPD Source: International Congress 2017 – Treatment and prevention of COPD exacerbation Year: 2017 Recommendations for bronchodilators and PDE4 inhibitors for prevention of exacerbations of COPD Source: International Congress 2017 – Treatment and prevention of COPD exacerbation Year: 2017 Pharmacological strategies for self-management of asthma exacerbations Source: Eur Respir J 2006; 28: 182-199 Year: 2006 Non-pharmacological treatment in asthma and COPD Source: ERS Course 2019 - Masterclass in airways disease 2019 Year: 2019 Macrolides in the prevention of COPD exacerbations Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease Year: 2012 Prevention and treatment of COPD exacerbations Source: International Congress 2018 – PG9 Chronic obstructive pulmonary disease exacerbations Year: 2018 An evaluation of exacerbations in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004 The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Prevention of COPD exacerbations: medications and other controversies Source: ERJ Open Res 2015; 1: 00011-2015 Year: 2015 Causes and management of exacerbations of COPD Source: ISSN=ISSN 1810-6838, ISBN=, page=250 Year: 2007 Prevention and management of COPD exacerbations Source: International Congress 2016 – China Session II Year: 2016 Impact of mucolytic treatment on COPD exacerbations Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Effect of roflumilast on exacerbations in patients with severe COPD and a prior history of hospitalization taking combination therapy Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Evaluation of COPD exacerbations using the EXACT-U Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015